DermAbiotech develops innovative targeted therapies for acute T cell-mediated inflammatory diseases.
DermAbiotech develops innovative targeted therapies for acute T cell-mediated inflammatory diseases.
Route de Florissant 53, 1206 Genève, Switzerland